The discovery of circulating fetal DNA in the plasma of pregnant women has greatly promoted advances in noninvasive prenatal testing. Screening performance is enhanced with higher fetal fraction and analysis of samples whose fetal DNA fraction is lower than 4% are unreliable. Although current approaches to fetal fraction measurement are accurate, most of them are expensive and time consuming. Here we present a simple and cost-effective solution that provides a quick and reasonably accurate fetal fraction by directly evaluating the size distribution of circulating DNA fragments in the extracted maternal cell-free DNA. The presented approach could be useful in the presequencing stage of noninvasive prenatal testing to evaluate whether the sample is suitable for the test or a repeat blood draw is recommended.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2144/btn-2020-0143 | DOI Listing |
Cardiovasc Toxicol
January 2025
Department of Physiology, Pharmacology, and Toxicology, West Virginia University, Morgantown, WV, 26505, USA.
Engineered nanomaterials (ENM) are capable of crossing the placental barrier and accumulating in fetal tissue. Specifically, the ENM nano-titanium dioxide (nano-TiO), has been shown to accumulate in placental and fetal tissue, resulting in decreased birthweight in pups. Additionally, nano-TiO is an established cardiac toxicant and regulator of glucose homeostasis, and exposure in utero may lead to serious maladaptive responses in cardiac development and overall metabolism.
View Article and Find Full Text PDFVet Anim Sci
March 2025
Doctorado en Ciencias Biológicas-Facultad de Ciencias Naturales-Universidad Autónoma de Querétaro. Av. de las Ciencias SN. Juriquilla. Santa Rosa Jáuregui, Querétaro, CP 76230, Mexico.
The study aimed to evaluate the effect of subclinical endometritis (SCE) on reproductive performance and identify risk factors for this pathology in small-scale dairies. In four small-scale dairies, 608 lactations were monitored for health issues, nutritional status, and reproductive events, and SCE was diagnosed based on endometrial polymorphonuclear counting (PMN%) at 30±5 (SCE30) and 60±5 (SCE60) days postpartum. The threshold for diagnosis was established according to the quartile distribution of PMN%; 4 % and 2 % for SCE30 and SCE60.
View Article and Find Full Text PDFJ Biol Eng
January 2025
Department of Traumatic Clinic, Shanghai East Hospital of Tongji University, Shanghai, 200120, China.
Objective: The direction of this study was to detect and analyze the specific mechanism of anti-apoptosis in mesenchymal stem cells (MSCs) cells caused by high expression of BCL2.
Methods: Bioinformatics was completed in Link omics. GO analysis and KEGG analysis were carried out, and the grope tool of Link omics database was used to evaluate PPI information and other core path analysis information.
Asian J Transfus Sci
September 2022
Department of Zoology, CCS HAU, Hisar, Haryana, India.
Context: Hemoglobinopathies are the most common heterogeneous group of monogenetic disorder in the world and its prevalence varies with geographical regions. India is developing country and many studies show a significant burden of hemoglobinopathies in India.
Aims: The aim of the present study was to check the prevalence of various hemoglobinopathies in anemic subjects using high-performance liquid chromatography (HPLC) method in Pune region which has multiple ethnic population groups from all parts of India.
Regen Ther
June 2024
Department of Medical and Translational Biology, Umeå University, SE-901 87 Umeå, Sweden.
Introduction: Before performing cell therapy clinical trials, it is important to understand how cells are influenced by different growth conditions and to find optimal xeno-free medium formulations. In this study we have investigated the properties of adipose tissue-derived stem cells (ASCs) cultured under xeno-free conditions.
Methods: Human lipoaspirate samples were digested to yield the stromal vascular fraction cells which were then seeded in i) Minimum Essential Medium-α (MEM-α) supplemented with 10 % (v/v) fetal bovine serum (FBS), ii) MEM-α supplemented with 2 % (v/v) human platelet lysate (PLT) or iii) PRIME-XV MSC expansion XSFM xeno-free, serum free medium (XV).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!